Press release
Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community
Up to $100,000 to be awarded for an innovative solution addressing an unmet need in the graft-versus-host disease (GVHD) community Visit
About this update from Incyte Corporation
[{"type":"text","content":"\n\nUp to $100,000 to be awarded for an innovative solution addressing an unmet need in the graft-versus-host disease (GVHD) community\n\n\n\n\nVisit www.IncyteIngenuityAward.com to apply now!\n\n\n WILMINGTON, Del.--(BUSINESS WIRE)--\nIncyte (Nasdaq:INCY) is proud to announce the opening call for submissions for its newly launched Incyte Ingenuity Award, an annual program created to support people living with graft-versus-host disease (GVHD), as well as their caregivers and physicians, by encouraging innovative and novel solutions for the challenges currently facing the GVHD community. Each year, the Incyte Ingenuity Award is expected to fund, up to $100,000, one innovative program, idea or initiative that fosters collaboration within the GVHD community to address a specific unmet need.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200219005221/en/\n\n“At Incyte, we wanted to create a community-driven program dedicated to improving the lives of patients with a serious disease, such as GVHD, which can be difficult to treat and have a devastating impact on the lives of patients,” said Barry Flannelly, Pharm. D., Executive Vice President and General Manager, U.S., Incyte. “Through the Incyte Ingenuity Award, we hope to spark creativity and innovation, which we expect to result in impactful and actionable solutions for the GVHD community.”\n\n\nSubmissions are welcomed from non-profit 501(c)(3), patient, policy and caregiver organizations, as well as healthcare providers and mid-level/junior faculty from healthcare organizations. Applications are due by April 30, 2020. All applications will be reviewed and evaluated by an independent judging panel, consisting of Gerry Cowden, Founder, Meredith Cowden Foundation; Shrina Duggal, PharmD, BCOP, Clinical Pharmacy Specialist; and Navneet Majhail, M.D., Director, Blood and Marrow Transplant Program, Cleveland Clinic. The judging panel will review each application and select the top three entries, who will then submit a more detailed proposal of their initiative. The first award recipient of Incyte Ingenuity Award will be announced in August of 2020.\n\n\n“Through my practice, I see first-hand the struggles faced by those impacted by GVHD. Everywhere they turn, patients experience a limitation – whether it is through limited s...